A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 254
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : PG
Long Form : pepsinogen
No. Year Title Co-occurring Abbreviation
2020 Cancer/testis antigen, Kita-Kyushu lung cancer antigen-1 and ABCD stratification for diagnosing gastric cancers. GC, H. pylori, KK-LC-1
2020 Serum miR-101-3p combined with pepsinogen contributes to the early diagnosis of gastric cancer. AG, CEA, GC, ROC
2020 Serum Pepsinogen Values in Japanese Junior High School Students With Reference to Helicobacter Pylori Infection. ---
2019 ABC Classification Is Less Useful for Older Koreans Born before 1960. CI, IgG, OR
2019 Analysis of factors associated with recovery of the serum pepsinogen ratio after Helicobacter pylori eradication: a long-term follow-up study in Korea. CI, OR
2019 Characteristics and Predictive Factor of Helicobacter pylori-Associated Functional Dyspepsia in Japanese Patients. FD, HP
2019 Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre study. GC
2019 Evaluation of serum markers for gastric cancer and its precursor diseases among high incidence and mortality rate of gastric cancer area. IM
2019 Feasibility of combined screening for upper gastrointestinal adenocarcinoma risk by serology and Cytosponge testing: the SUGAR study. TFF3
10  2019 GWAS analysis reveals a significant contribution of PSCA to the risk of Heliobacter pylori-induced gastric atrophy. FDR, GA, GWASs, HERPACC2, HP, J-MICC, PSCA, SKAT, SNPs
11  2019 Helicobacter pylori (HP) infection alone, but not HP-induced atrophic gastritis, increases the risk of gastric lymphoma: a case-control study in Japan. CIs, DLBCL, H. pylori, HP, ORs
12  2019 Helicobacter pylori antibody and pepsinogen testing for predicting gastric microbiome abundance. HP
13  2019 Optimal Criteria and Diagnostic Ability of Serum Pepsinogen Values for Helicobacter pylori Infection. CLIA, LA
14  2019 Prediction of Chronic Atrophic Gastritis and Gastric Neoplasms by Serum Pepsinogen Assay: A Systematic Review and Meta-Analysis of Diagnostic Test Accuracy. CAG, GC, sPGA
15  2019 Prevalence of Atrophic Gastritis in Kazakhstan and the Accuracy of Pepsinogen Tests to Detect Gastric Mucosal Atrophy. ---
16  2019 Serum Pepsinogen as a Predictor for Gastric Cancer Death: A 16-Year Community-based Cohort Study. CI, HR
17  2019 Sex differences in the prevalence of Helicobacter pylori infection: an individual participant data pooled analysis (StoP Project). CIs, H. pylori, ORs, PRs, StoP
18  2019 Significance of Serological Gastric Biopsy in Different Gastric Mucosal Lesions: an Observational Study. H. pylori
19  2019 Surveillance of premalignant gastric lesions: a multicentre prospective cohort study from low incidence regions. AG, IM, OLGIM
20  2019 The value of detecting pepsinogen and gastrin-17 levels in serum for pre-cancerous lesion screening in gastric cancer. AUCs, CAG, PGR, ROC
21  2019 The Value of Pepsinogen in GC Screening: A Systematic Review and Meta-Analysis. GC, MA
22  2019 [Comparison of different serological methods in screening early gastric cancer]. AUC, EGC, Hp, ROC
23  2018 Association between atherosclerosis and gastric biomarkers concerning Helicobacter pylori infection in a Chinese healthy population. HP, R-CIMT
24  2018 Characteristics of Helicobacter pylori-seropositive subjects according to the stool antigen test findings: a prospective study. ---
25  2018 Characterization of Helicobacter pylori-Naive Early Gastric Cancers. GCs, MUC6, SMT
26  2018 Cost-effectiveness of combined serum anti-Helicobacter pylori IgG antibody and serum pepsinogen concentrations for screening for gastric cancer risk in Japan. HPA
27  2018 Endoscopic submucosal dissection for the diagnosis and therapy of pedunculated gastric cancer with prolapse into the duodenal bulb: A case report. CT, ESD, Hp
28  2018 Epstein-Barr virus infection associated with pepsinogens and Helicobacter pylori infection in patients with gastric cancer. EBERs, EBV, HP
29  2018 Gastric Cancer Screening by Combined Determination of Serum Helicobacter pylori Antibody and Pepsinogen Concentrations: ABC Method for Gastric Cancer Screening. ---
30  2018 HIV related hypochlorhydria does not appear to respond to anti-retroviral therapy in Zambian adults: a case control study. ART, HIV
31  2018 Low PG I/II ratio as a marker of atrophic gastritis: Association with nutritional and metabolic status in healthy people. AG
32  2018 Narrow band imaging and serology in the assessment of premalignant gastric pathology. ---
33  2018 Pepsinogen test for the evaluation of precancerous changes in gastric mucosa: a population-based study. ---
34  2018 Polymorphism rs7521584 in miR‑429 is associated with the severity of atrophic gastritis in patients with Helicobacterpylori infection. AG group, CI, OR
35  2018 Predicting the Development of Gastric Neoplasms in a Healthcare Cohort by Combining Helicobacter pylori Antibodies and Serum Pepsinogen: A 5-Year Longitudinal Study. HP
36  2018 Serum pepsinogen levels indicate the requirement of upper gastrointestinal endoscopy among Group A subjects of ABC classification: a multicenter study. UBT
37  2018 The histologic detection of Helicobacter pylori in seropositive subjects is affected by pathology and secretory ability of the stomach. AUC
38  2018 [Comparison of two serological methods in screening gastric cancer and its precancerous condition]. ELISA, HP
39  2017 A significant increase in the pepsinogen I/II ratio is a reliable biomarker for successful Helicobacter pylori eradication. H. pylori, UBT
40  2017 Changes with aging in gastric biomarkers levels and in biochemical factors associated with Helicobacter pylori infection in asymptomatic Chinese population. FBG, H. pylori, LDL-C
41  2017 Characteristics of gastric cancer in negative test of serum anti-Helicobacter pylori antibody and pepsinogen test: a multicenter study. CAG, H. pylori
42  2017 Comparison of serum trefoil factor 3 with the pepsinogen test for the screening of diffuse-type gastric cancer. TFF3
43  2017 Cutoff Pepsinogen Level for Predicting Unintendedly Eradicated Cases of Helicobacter pylori Infection in Subjects with Seemingly Normal Pepsinogen Levels. ROC
44  2017 Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer. GC, HP
45  2017 Factors Related to Upper Gastrointestinal Symptom Generation in 2275 Helicobacter pylori Seroprevalent Adults. UGI
46  2017 Helicobacter pylori infection and serum level of pepsinogen are associated with the risk of metachronous gastric neoplasm after endoscopic resection. EGCs, HR, OR
47  2017 Link between Serum Pepsinogen Concentrations and Upper Gastrointestinal Endoscopic Findings. IgG, NG, UGI
48  2017 Natural Course of Helicobacter pylori Infection in Japanese Hemodialysis Patients. H. pylori
49  2017 Receiver operating characteristic analysis of prediction for gastric cancer development using serum pepsinogen and Helicobacter pylori antibody tests. ---
50  2017 Serological Evaluation of Gastric Cancer Risk Based on Pepsinogen and Helicobacter pylori Antibody: Relationship to Endoscopic Findings. CAG, Hp-Ab
51  2017 The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China. ANOVA, GC, HP, IM, OLGA, OLGIM
52  2017 The Impact of Gastric Atrophy on the Incidence of Diabetes. H. pylori
53  2017 The potential value of serum pepsinogen for the diagnosis of atrophic gastritis among the health check-up populations in China: a diagnostic clinical research. AG, HP, OLGA
54  2017 The serum pepsinogen levels for risk assessment of gastric neoplasms: New proposal from a case-control study in Korea. OR
55  2017 The Serum Pepsinogen Test as a Predictor of Kazakh Gastric Cancer. AUC, GC, PGR
56  2017 [Serological Changes after Equivocal Helicobacter pylori-serology Test Findings Dependent on Gastric Secreting Ability]. H. pylori, IgG, UGI
57  2016 Actual Status of Involvement of Helicobacter pylori Infection That Developed Gastric Cancer from Group A of ABC (D) Stratification - Study of Early Gastric Cancer Cases That Underwent Endoscopic Submucosal Dissection. ESD
58  2016 Decrease of serum total ghrelin in extensive atrophic gastritis: comparison with pepsinogens in histological reference. BMI, CGC, CLC, ROC
59  2016 Does the antibody production ability affect the serum anti-Helicobacter pylori IgG titer? H. pylori, HBsAb, HBsAg, IgG
60  2016 Effects of Lactobacillus gasseri OLL2716 on Helicobacter pylori-Associated Dyspepsia: A Multicenter Randomized Double-Blind Controlled Trial. UBT
61  2016 Gastric cancer - clinical and epidemiological aspects. GC
62  2016 Method evaluation of pepsinogen I/II assay based on chemiluminescent immunoassays and comparison with other test methods. AG, LoB, LOD
63  2016 Oxyntic gastric atrophy in Helicobacter pylori gastritis is distinct from autoimmune gastritis. AIG, AUCs, OGA
64  2016 Relationship between ghrelin, Helicobacter pylori and gastric mucosal atrophy in hemodialysis patients. H. pylori
65  2016 Serum Pepsinogen Levels Are Correlated With Age, Sex and the Level of Helicobacter pylori Infection in Healthy Individuals. HP, PG I, PG II
66  2016 Serum pepsinogen levels can quantify the risk of development of metachronous gastric cancer after endoscopic resection. ER, MGC
67  2016 Severity of Gastric Mucosal Atrophy Is the Major Determinant of Plasma Ghrelin Level in Hemodialysis Patients. HD
68  2016 Stomach-specific Biomarkers (GastroPanel) Can Predict the Development of Gastric Cancer in a Caucasian Population: A Longitudinal Nested Case-Control Study in Siberia. AG, COs, GC
69  2016 The new modified ABCD method for gastric neoplasm screening. ---
70  2015 Autoimmune gastritis in autoimmune thyroid disease. ---
71  2015 Correlation between the ABC classification and radiological findings for assessing gastric cancer risk. HP
72  2015 Diagnosis of Helicobacter pylori-induced gastritis by serum pepsinogen levels. ---
73  2015 First-line eradication for Helicobacter pylori-positive gastritis by esomeprazole-based triple therapy is influenced by CYP2C19 genotype. EM, EPZ, H. pylori, PPIs
74  2015 Helicobacter pylori Antibody Titer and Gastric Cancer Screening. ---
75  2015 Helicobacter pylori Infection Status Correlates with Serum Parameter Levels Responding to Multi-organ Functions. ---
76  2015 Identification of a high-risk group for low-dose aspirin-induced gastropathy by measuring serum pepsinogen in H. pylori-infected subjects. LDA
77  2015 Influence of prostate stem cell antigen gene polymorphisms on susceptibility to Helicobacter pylori-associated diseases: a case-control study. OR, PSCA
78  2015 Prevalence of Helicobacter pylori infection and atrophic gastritis in patients with dyspeptic symptoms in Myanmar. H. pylori
79  2015 The association between objective tongue color and endoscopic findings: results from the Kyushu and Okinawa population study (KOPS). EG, KOPS, OR, SAG, TC
80  2015 The relationship between iron deficiency in patients with Helicobacter pylori-infected nodular gastritis and the serum prohepcidin level. Ab, DU, GHP, GU, H. pylori, IDA, NG
81  2015 [Characteristics of group A patients according to the ABC classification for gastric cancer risk screening]. ---
82  2014 Advanced method for evaluation of gastric cancer risk by serum markers: determination of true low-risk subjects for gastric neoplasm. ---
83  2014 Age-dependent association among Helicobacter pylori infection, serum pepsinogen levels and immune response of children to live oral cholera vaccine CVD 103-HgR. ---
84  2014 Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer. CAG, CI, HR
85  2014 Combining the serum pepsinogen level and Helicobacter pylori antibody test for predicting the histology of gastric neoplasm. H. pylori
86  2014 Diagnostic values of serum levels of pepsinogens and gastrin-17 for screening gastritis and gastric cancer in a high risk area in northern Iran. GA, GC, ROC
87  2014 Helicobacter pylori infection affects immune responses following vaccination of typhoid-naive U.S. adults with attenuated Salmonella typhi oral vaccine CVD 908-htrA. CI, IgG, LPS, OR
88  2014 Helicobacter pylori infection and pepsinogen levels have clinical significance in hypertension patients. HP
89  2014 Light blue crest and ridge/villous patterns in the uninvolved gastric antrum by magnifying NBI endoscopy correlate with serum pepsinogen and gastric cancer occurrence. GC, GC, IM, LBC, NBI
90  2014 Marked decrease in serum pepsinogen II levels resulting from endoscopic resection of a large duodenal tumor. ---
91  2014 Serum anti-Helicobacter pylori immunoglobulin G titer correlates with grade of histological gastritis, mucosal bacterial density, and levels of serum biomarkers. IgG
92  2014 Serum Helicobacter pylori CagA antibody titer as a useful marker for advanced inflammation in the stomach in Japan. ---
93  2014 Serum trefoil factor 3 is a promising non-invasive biomarker for gastric cancer screening: a monocentric cohort study in China. CAG, CNAG, ELISA, ROC, TFF
94  2014 The value of serum pepsinogen levels for the diagnosis of gastric diseases in Chinese Han people in midsouth China. ---
95  2014 [Changes of serum pepsinogen I/II ratio induced by Helicobacter pylori infection in hypertensive patients]. AUC, HDL, HP, ROC
96  2013 Comparison of the effect of a single dose of omeprazole or lansoprazole on intragastric pH in Japanese participants: a two-way crossover study. PPIs
97  2013 Effect of Helicobacter pylori infection on esophagogastric variceal bleeding in patients with liver cirrhosis and portal hypertension. ---
98  2013 Exploratory findings of audiometry in adult patients with otitis media with high pepsinogen concentrations: a preliminary study. BC, OME
99  2013 Gastric cancer detection using gastric juice pepsinogen and melanoma-associated gene RNA. MAGE
100  2013 Gene expression and activity of digestive enzymes during the larval development of Asian seabass (Lates calcarifer). ALP, AMY, BAL, ctr, LAP, try